Visibility Score
56/100
AI Mentions
430
AI Search Volume
94.2K
As of June 25, 2026, Masimo (masimo.com) has an AI visibility score of 56 out of 100, based on 430 total AI mentions across platforms like Google AI Overview and ChatGPT. The brand generates 94.2K AI search volume. Compared to peers in the life sciences sector, Masimo ranks #3 of 6 in AI mention share of voice.
Masimo is a US-based medical device company in the Patient Monitoring segment, registered with the U.S. FDA. This report tracks how Masimo appears in AI search — ChatGPT, Google AI Overview and other answer engines.
AI Visibility Breakdown
Masimo has 430 total AI mentions across 2 tracked platforms, generating 94.2K in AI search volume. Google AI Overview accounts for the largest share at 88% of mentions.
By Platform
Brand Entities
No brand entity data available.
Where AI Sources Its Answers About Masimo
When AI assistants answer questions involving Masimo, these are the domains they most often cite. Winning AI visibility means being present and referenced on the sources the model actually reads — which is rarely a company's own website.
Share of Voice vs Competitors
Masimo ranks #3 out of 6 competitors in AI mention share of voice, capturing 5% of total mentions. Dexcom leads with 7.8K AI mentions. Competitors tracked include Dexcom, Mindray, Embecta, Tandem Diabetes Care.
AI Mentions
Comparison
| Company | Mentions | AI Vol |
|---|---|---|
| dexcom.com (Dexcom) | 7.8K | 14.7M |
| mindray.com (Mindray) | 985 | 505.0K |
| masimo.com (You) | 430 | 94.2K |
| embecta.com (Embecta) | 127 | 25.6K |
| tandemdiabetes.com (Tandem Diabetes Care) | 85 | 1.5K |
| nihonkohden.com (Nihon Kohden) | 60 | 6.9K |
Improve your brand's AI visibility
This is a static snapshot. Ongoing AI-visibility monitoring, competitor benchmarking, and the source-grounded GEO content that improves your citation footprint are included in VayoMed's Done-for-You Growth Engine.